Skip to Main Content
Phase COVID-NA

Advanced Cardiovascular Magnetic Resonance for Detection of Programmed Cell Death Protein-1 Deficient Myocarditis

  • Study HIC#:2000023943
  • Last Updated:07/15/2021

We hypothesize that advanced CMR can detect myocardial structural, functional, and metabolic changes associated with autoimmune myocarditis in cardio-toxicity associated with CPI therapy of the PD-1 pathway in cancer patients. We propose to do this by applying advanced CMR methods for edema and fibrosis to detect early inflammation and cardio-toxicity in patients receiving CPI therapy.

  • Start Date10/29/2018
  • End Date09/30/2022

Sub-Investigator

For more information about this study, contact:

    Or contact the Help us Discover team on: